Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Packard

Showing results (131-140 of 235) with videos related to

Pageof 24
Sort By:
Arteriosclerosis (Dallas, Tex.)|March 1, 1985
Fenofibrate reduces low density lipoprotein catabolism in hypertriglyceridemic subjectsJ Shepherd, M J Caslake, A R Lorimer, et al.
The Journal of Clinical Investigation|June 1, 1978
Effects of dietary polyunsaturated and saturated fat on the properties of high density lipoproteins and the metabolism of apolipoprotein A-IJ Shepherd, C J Packard, J R Patsch, et al.
Biochemical Society Transactions|December 1, 1990
Genetic and environmental modulation of low-density lipoprotein catabolismA Gaw, B A Griffin, D Gaffney, et al.
Atherosclerosis|February 10, 1997
In vivo metabolism of apo A-I and apo A-II in subjects with apo A-I(Lys107-->0) associated with reduced HDL cholesterol and Lp(AI w AII) deficiencyM Tilly-Kiesi, C J Packard, J Kahri, et al.
Annals of Clinical Biochemistry|March 1, 1990
The relationship between serum cholesterol and serum thyrotropin, thyroxine and tri-iodothyronine concentrations in suspected hypothyroidismJ Elder, A McLelland, D S O'Reilly, et al.
Kidney International|September 6, 2000
Patients with nephrotic-range proteinuria have apolipoprotein C and E deficient VLDL1C J Deighan, M J Caslake, M McConnell, et al.
Atherosclerosis|June 28, 2001
The atherogenic lipoprotein phenotype: small dense LDL and lipoprotein remnants in nephrotic range proteinuriaC J Deighan, M J Caslake, M McConnell, et al.
Atherosclerosis|January 8, 2008
Distinct patterns of heparin affinity chromatography VLDL1 and VLDL2 subfractions in the different dyslipidaemiasL Duvillard, M J Caslake, J M Petit, et al.
European Journal of Clinical Investigation|June 1, 1992
Effects of cholestyramine and acipimox on subfractions of plasma low density lipoprotein. Studies in normolipidaemic and hypercholesterolaemic subjectsB A Griffin, M J Caslake, A Gaw, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 12, 1998
Increased atherogenicity of low-density lipoprotein in heavy proteinuriaC J Deighan, M J Caslake, M McConnell, et al.
Pageof 24

Showing results (131-140 of 235) with videos related to

Sort By:
Pageof 24
Arteriosclerosis (Dallas, Tex.)|March 1, 1985
Fenofibrate reduces low density lipoprotein catabolism in hypertriglyceridemic subjectsJ Shepherd, M J Caslake, A R Lorimer, et al.
The Journal of Clinical Investigation|June 1, 1978
Effects of dietary polyunsaturated and saturated fat on the properties of high density lipoproteins and the metabolism of apolipoprotein A-IJ Shepherd, C J Packard, J R Patsch, et al.
Biochemical Society Transactions|December 1, 1990
Genetic and environmental modulation of low-density lipoprotein catabolismA Gaw, B A Griffin, D Gaffney, et al.
Atherosclerosis|February 10, 1997
In vivo metabolism of apo A-I and apo A-II in subjects with apo A-I(Lys107-->0) associated with reduced HDL cholesterol and Lp(AI w AII) deficiencyM Tilly-Kiesi, C J Packard, J Kahri, et al.
Annals of Clinical Biochemistry|March 1, 1990
The relationship between serum cholesterol and serum thyrotropin, thyroxine and tri-iodothyronine concentrations in suspected hypothyroidismJ Elder, A McLelland, D S O'Reilly, et al.
Kidney International|September 6, 2000
Patients with nephrotic-range proteinuria have apolipoprotein C and E deficient VLDL1C J Deighan, M J Caslake, M McConnell, et al.
Atherosclerosis|June 28, 2001
The atherogenic lipoprotein phenotype: small dense LDL and lipoprotein remnants in nephrotic range proteinuriaC J Deighan, M J Caslake, M McConnell, et al.
Atherosclerosis|January 8, 2008
Distinct patterns of heparin affinity chromatography VLDL1 and VLDL2 subfractions in the different dyslipidaemiasL Duvillard, M J Caslake, J M Petit, et al.
European Journal of Clinical Investigation|June 1, 1992
Effects of cholestyramine and acipimox on subfractions of plasma low density lipoprotein. Studies in normolipidaemic and hypercholesterolaemic subjectsB A Griffin, M J Caslake, A Gaw, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 12, 1998
Increased atherogenicity of low-density lipoprotein in heavy proteinuriaC J Deighan, M J Caslake, M McConnell, et al.
Pageof 24